Gender Male
Dr. Wang Yu has more than 15 years of experience in the clinical development of anti-tumor drugs. He currently serves as the chief medical officer of Jinfang Medicine and is fully responsible for the strategy and operation of each department of Jinfang Medicine's clinical development. His clinical research and development experience covers
tumor chemotherapy drugs, small molecule targeted drugs, therapeutic vaccines, oncolytic viruses, immune checkpoint inhibitors and cell therapy, covering solid tumors and hematological tumors.
